ResMed Inc.

RMD Healthcare Medical Instruments & Supplies

ResMed Inc.’s revenue for fiscal 2026 (year ended June 2026) was $5.7 billion, up 9.85% from fiscal 2025. In the quarter to June 2026, revenue grew 8.58%, EPS grew 2.32%, free cash flow fell 21.3% and total debt fell 39.3%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for ten, operating cash flow growth for three.

238.97 3.26 −1.35%
Market cap
$34.1B
P/E
22.8×
Fwd P/E
16.6×
Dividend yield
1.03%
F-score
6/9
Altman Z
10.00
Beneish M
−2.59
Dividend safety
96/100
Older periods Sep '25 Dec '25 Mar '26 Jun '26
P/E ratio

+8 more quarters

27.90 23.73 21.58 18.63
P/S ratio
7.61 6.51 5.89 5.02
P/FCF ratio
22.78 19.77 18.79 17.41
P/Operating CF
87.50 103.40 58.88 62.38
P/B ratio
6.54 5.56 5.03 4.31
Price to Tangible BV
15.21 12.34 10.79 8.80
EV/Sales
7.43 6.32 5.66 4.83
EV/EBITDA
19.67 16.52 14.55 12.81
EV/Operating CF
20.73 17.82 16.60 15.11
EV/FCF
22.22 19.20 18.07 16.76
Quick Ratio
1.82 1.93 1.97 1.80
Current Ratio
2.89 3.06 3.01 3.10
Net Debt/EBITDA
(1.93) (1.83) (2.21) (2.12)
Debt/Assets
4.92% 4.75% 4.60% 4.45%
Debt/Equity
0.07 0.06 0.06 0.06
Asset Turnover
0.68 0.69 0.68 0.66
Operating CF/Net income
1.31 0.87 1.39 1.19
Capex/Depreciation
(0.79) (0.55) (0.57) (1.04)
Interest Coverage
(50.78) (61.85) (40.68) (21.48)
Research and Development Expense of Revenue
6.54% 6.39% 6.59% 7.22%
Selling, General and Administrative Expense of Revenue
19.41% 19.57% 19.96% 20.24%
Intangible Assets out of Total Assets
0.42 0.41 0.39 0.38
Share Based Compensation of Revenue
1.58% 2.03% 1.87% 1.88%
Graham Net Nets
0.04 0.05 0.05 0.07
Graham Number
96.14 99.49 102.24 103.20
Earnings Yield
3.58% 4.21% 4.63% 5.37%
Free Cash Flow Yield
4.39% 5.06% 5.32% 5.74%
Revenue per Share
9.14 9.76 9.85 10.06
Operating CF per Share
3.13 2.33 3.81 3.12
Capex per Share
(0.31) (0.24) (0.27) (0.39)
Free Cash Flow per Share
2.82 2.09 3.54 2.73
Cash per Share
9.47 9.72 11.43 10.10
Shareholders Equity per Share
41.87 43.34 44.67 45.25
Interest Debt per Share
0.00 0.00 0.00 0.00
Book value per Share
41.87 43.34 44.67 45.25
Free Cash Flow
411.54 305.19 514.54 397.38
Working Capital
2,370.23 2,570.69 2,712.85 2,929.63
Capital Expenditures
(45.78) (34.55) (39.59) (57.25)
Net Current Asset Value
1,438.65 1,636.31 1,771.69 1,944.18
EV/EBIT
22.38 18.76 16.58 14.46
Capex to Sales
0.03 0.02 0.03 0.04
Price to Operating Income
22.94 19.31 17.24 15.03
Other line items
Average Receivables
859.23 922.79 953.33 987.86
Average Payables
258.03 235.36 247.93 293.54
Average Inventory
931.89 902.07 887.26 936.76
Average Assets
7,765.38 7,822.35 8,175.55 8,570.17
Average Common Equity
5,658.15 5,786.94 6,019.02 6,276.63

Fold the line items

Columns are period end dates